Table 5. | Assessment of the risk of bias for included controlled clinical studies |
Study |
Random sequence generation |
Allocation concealment |
Blinding |
Incomplete outcome data |
Selective reporting |
Other bias |
Summary assessment |
---|---|---|---|---|---|---|---|
Tallarico et al. [27] | Low | Low | Low | Low | Low | Low | Low |
Cardaropoli et al. [29] | Low | Unclear | Unclear | Low | Low | Low | Unclear |
Barone et al. [30] | Unclear | Low | Low | Low | Low | Low | Low |
Marconcini et al. [31] | Low | Low | Unclear | Low | Low | Unclear | Low |
Felice et al. [32] | Low | Unclear | Unclear | Low | Low | High | Unclear |
Esposito et al. [33] | Low | Low | Low | Low | Low | Unclear | Low |
Esposito et al. [34] | Low | High | Low | Low | Low | Unclear | Low |